gland pharma glp-1 capacity expansion reported a strong December quarter with 22.5% revenue growth and 27% YoY profit growth, driven by healthy performance across the US, India, and Europe. The stock reacted positively, gaining over German quantity:6 Seems like there's officially

gland pharma glp-1 capacity expansion reported a strong December quarter with 22.5% revenue growth and 27% YoY profit growth, driven by healthy performance across the US, India, and Europe. The stock reacted positively, gaining over German quantity:6 Seems like there's officially

Seems like there's officially an underground GLP-1 market in South Africa..., #thefeedcpt #capetown

Clinical trials show they can help patients lose 15-25% of their total body weight numbers that were once only possible with bariatric surgery

German

quantity:6

Reported example tiers for GLP-1s in public discussions include lower-cost monthly injectables and starter oral pricing that significantly cut initial costs